Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Operating Expenses: 2023-2024

Historic Operating Expenses for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $67.5 million.

  • Artiva Biotherapeutics' Operating Expenses rose 27.56% to $18.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $67.5 million, marking a year-over-year change of. This contributed to the annual value of $67.5 million for FY2024, which is 5.25% up from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Operating Expenses of $67.5 million as of FY2024, which was up 5.25% from $64.2 million recorded in FY2023.
  • In the past 5 years, Artiva Biotherapeutics' Operating Expenses ranged from a high of $67.5 million in FY2024 and a low of $64.2 million during FY2023.
  • Its 2-year average for Operating Expenses is $65.8 million, with a median of $65.8 million in 2023.
  • Data for Artiva Biotherapeutics' Operating Expenses shows a peak YoY rose of 5.25% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Artiva Biotherapeutics' Operating Expenses stood at $64.2 million in 2023, then grew by 5.25% to $67.5 million in 2024.